What You Should Know: Noom, a digital healthcare company, is shaking up the weight loss industry with the launch of Noom GLP-1Rx, an innovative program offers affordable, accessible, and sustainable weight loss by combining compounded GLP-1 injections with Nooms proven behavioral change program
The maximum semaglutide dose recommended by the FDA for weight loss is 2.4 mg once weekly, which is specifically indicated for patients with obesity or overweight conditions who have at least one weight-related comorbidity
Many people who started with prediabetes have normal glucose levels
The peptide blocks ferritin channels, preventing release of tissue-damaging free iron after tissue injury
These services provide confidential advice, needle exchange programmes, and support for safer use or cessation
Alternatively, you can book a consultation using our appointment request form